Importance of medication reconciliation in cancer patients
Open Access
- 29 November 2021
- journal article
- research article
- Published by Taylor & Francis in Journal of Pharmaceutical Policy and Practice
- Vol. 14 (1) , 1-10
Abstract
Cancer patients are a complex and vulnerable population whose medication history is often extensive. Medication reconciliations in this population are especially essential, since medication discrepancies can lead to dire outcomes. This commentary aims to describe the significance of conducting medication reconciliations in this often-forgotten patient population. We discuss additional clinical interventions that can arise during this process as well. Medication reconciliations provide the opportunity to identify and prevent drug–drug and herb–drug interactions. They also provide an opportunity to appropriately adjust chemotherapy dosing according to renal and hepatic function. Finally, reconciling medications can also provide an opportunity to identify and deprescribe inappropriate medications. While clinical impact appears evident in this landscape, evidence of economic impact is lacking. As more cancer patients are prescribed a combination of oral chemotherapies, intravenous chemotherapies and non-anticancer medications, future studies should evaluate the advantages of conducting medication reconciliations in these patient populations across multiple care settings.Keywords
This publication has 55 references indexed in Scilit:
- Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trialThe Lancet, 2013
- Hospitalisation for venous thromboembolism in cancer patients and the general population: a population-based cohort study in Denmark, 1997–2006British Journal of Cancer, 2010
- Prevalence of Complementary Medicine Use in Pediatric Cancer: A Systematic ReviewPediatrics, 2010
- Selective serotonin reuptake inhibitors and breast cancer mortality in women receiving tamoxifen: a population based cohort studyBMJ, 2010
- Major depression after breast cancer: a review of epidemiology and treatmentGeneral Hospital Psychiatry, 2008
- Liver cirrhosisThe Lancet, 2008
- Vitamin and Mineral Supplement Use Among US Adults After Cancer Diagnosis: A Systematic ReviewJournal of Clinical Oncology, 2008
- Comprehensive Evaluation of Tamoxifen Sequential Biotransformation by the Human Cytochrome P450 System in Vitro: Prominent Roles for CYP3A and CYP2D6The Journal of Pharmacology and Experimental Therapeutics, 2004
- Venous Thromboembolism and Cancer: Risks and OutcomesCirculation, 2003
- A summated score for the medication appropriateness index: development and assessment of clinimetric properties including content validityJournal of Clinical Epidemiology, 1994